{"id":450088,"date":"2021-03-03T16:33:16","date_gmt":"2021-03-03T21:33:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450088"},"modified":"2021-03-03T16:33:16","modified_gmt":"2021-03-03T21:33:16","slug":"flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/","title":{"rendered":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BURLINGTON, Mass., March  03, 2021  (GLOBE NEWSWIRE) &#8212; Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2020 financial results after the close of the U.S. financial markets on Wednesday, March 10, 2021.<\/p>\n<p>A live webcast of the conference call can be accessed through the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nRQW7T9NvZxl_YNiavWEpqlI29jbn8sc9ruLhCo6dKlrLgW7X-PwnRLnGbePJBlka68ogTpMZ2Ua2YXe3HEBsQU5clfu1-vayDOwneWRK84u3UDVEbKlztswA4v2G8BIjwIe5lSmGl79y19tFUvYdCd9qHVTMUOLPU01u0JtGmQ0J7Kd4p9ST9QqvqfpP3y4xZPggLiGI8a9y1Haa7y1f0XV5vr5NzhXsdeS1hS1JSPx0zKL2BaqzUcVY4jqEmnb\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors<\/a>\u201d tab on the\u00a0Flexion Therapeutics\u00a0website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID #7657415. Please dial in at least 15 minutes in advance to ensure a timely connection to the call.<\/p>\n<p>\n        <strong>About Flexion Therapeutics<\/strong><br \/>\n        <br \/>Flexion Therapeutics\u00a0(Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company&#8217;s core values are focus, ingenuity, tenacity, transparency and fun. Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8ButtgAkspWA9rdzIIt7xcstkCaYoYyiFNfyaZ8y2INTLaJ7konlNZXlYOo6PbkZDcmG283JG3B7_MD0EhCfhdosJH00RYB4YGFjdymw9qg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">flexiontherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Scott Young<br \/>Vice President, Corporate Communications &amp; Investor Relations<br \/>T: 781-305-7194<br \/>syoung@flexiontherapeutics.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b70ba04a-d4f6-403e-a970-da986f68ae2a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BURLINGTON, Mass., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2020 financial results after the close of the U.S. financial markets on Wednesday, March 10, 2021. A live webcast of the conference call can be accessed through the \u201cInvestors\u201d tab on the\u00a0Flexion Therapeutics\u00a0website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID #7657415. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. About Flexion Therapeutics Flexion Therapeutics\u00a0(Nasdaq:FLXN) is a biopharmaceutical company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450088","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BURLINGTON, Mass., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2020 financial results after the close of the U.S. financial markets on Wednesday, March 10, 2021. A live webcast of the conference call can be accessed through the \u201cInvestors\u201d tab on the\u00a0Flexion Therapeutics\u00a0website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID #7657415. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. About Flexion Therapeutics Flexion Therapeutics\u00a0(Nasdaq:FLXN) is a biopharmaceutical company focused &hellip; Continue reading &quot;Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-03T21:33:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021\",\"datePublished\":\"2021-03-03T21:33:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/\"},\"wordCount\":186,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/\",\"name\":\"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\",\"datePublished\":\"2021-03-03T21:33:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/","og_locale":"en_US","og_type":"article","og_title":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk","og_description":"BURLINGTON, Mass., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2020 financial results after the close of the U.S. financial markets on Wednesday, March 10, 2021. A live webcast of the conference call can be accessed through the \u201cInvestors\u201d tab on the\u00a0Flexion Therapeutics\u00a0website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID #7657415. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. About Flexion Therapeutics Flexion Therapeutics\u00a0(Nasdaq:FLXN) is a biopharmaceutical company focused &hellip; Continue reading \"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-03T21:33:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021","datePublished":"2021-03-03T21:33:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/"},"wordCount":186,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/","name":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=","datePublished":"2021-03-03T21:33:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzkyNSM0MDQ3MDYyIzIwMDM5NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/flexion-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-10-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450088"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450088\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}